Literature DB >> 11692008

Mitochondrial disease and stroke.

E Martínez-Fernández1, A Gil-Peralta, R García-Lozano, I Chinchón, I Aguilera, O Fernández-López, J Arenas, Y Campos, J Bautista.   

Abstract

BACKGROUND AND
PURPOSE: It is well known that some mitochondrial disorders are responsible for ischemic cerebral infarction in young patients. Our purpose was to determine, in this prospective ongoing study, whether ischemic stroke is the only manifestation of a mitochondrial disorder in young patients.
METHODS: Patients aged </=50 years, admitted to the Stroke Unit from January 1999 to May 2000 with a diagnosis of ischemic stroke of unknown origin, were included in the study. All of them had full biochemical and hematologic tests, neuroimaging studies, transesophageal echocardiography, and extracranial and transcranial Doppler sonography. Patent foramen ovale was ruled out. Lactic acid concentrations were measured after anaerobic exercise of the forearm, and a morphological, biochemical, and molecular study after biceps muscle biopsy was performed.
RESULTS: Of the 18 patients so far included, 3 (17%) presented lactic acid hyperproduction after physical exercise, and 6 (33%) showed deficit of the mitochondrial respiratory chain complexes. The molecular analyses have confirmed mitochondrial mutations at base pairs 3243 (characteristic of mitochondrial encephalomyopathy, lactic acidosis, and strokelike episodes [MELAS]), 4216, and 15 928.
CONCLUSIONS: These results suggest that ischemic stroke may be the only manifestation or the initial manifestation of a mitochondrial disorder.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11692008     DOI: 10.1161/hs1101.098328

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  MR diffusion tensor imaging, fiber tracking, and single-voxel spectroscopy findings in an unusual MELAS case.

Authors:  Denis Ducreux; Ghaidaa Nasser; Catherine Lacroix; David Adams; Pierre Lasjaunias
Journal:  AJNR Am J Neuroradiol       Date:  2005-08       Impact factor: 3.825

Review 2.  [Cerebral CT and MRI in mitchondrial disorders].

Authors:  J Finsterer
Journal:  Nervenarzt       Date:  2009-06       Impact factor: 1.214

Review 3.  Stroke Risk Factors, Genetics, and Prevention.

Authors:  Amelia K Boehme; Charles Esenwa; Mitchell S V Elkind
Journal:  Circ Res       Date:  2017-02-03       Impact factor: 17.367

Review 4.  Environmental exposure and mitochondrial epigenetics: study design and analytical challenges.

Authors:  Hyang-Min Byun; Andrea A Baccarelli
Journal:  Hum Genet       Date:  2014-01-09       Impact factor: 4.132

5.  Cerebrospinal fluid neurone-specific enolase in mitochondrial encephalomyopathies.

Authors:  Josef Finsterer; Markus Exner; Helmut Rumpold
Journal:  Metab Brain Dis       Date:  2005-03       Impact factor: 3.584

6.  Pathophysiology of vascular dementia.

Authors:  Francesco Iemolo; Giovanni Duro; Claudia Rizzo; Laura Castiglia; Vladimir Hachinski; Calogero Caruso
Journal:  Immun Ageing       Date:  2009-11-06       Impact factor: 6.400

7.  Biological response of zebrafish embryos after short-term exposure to thifluzamide.

Authors:  Yang Yang; Wenxian Liu; Xiyan Mu; Suzhen Qi; Bin Fu; Chengju Wang
Journal:  Sci Rep       Date:  2016-12-07       Impact factor: 4.379

8.  The creation of cybrids harboring mitochondrial haplogroups in the Taiwanese population of ethnic Chinese background: an extensive in vitro tool for the study of mitochondrial genomic variations.

Authors:  Tsu-Kung Lin; Hung-Yu Lin; Shang-Der Chen; Yao-Chung Chuang; Jiin-Haur Chuang; Pei-Wen Wang; Sheng-Teng Huang; Mao-Meng Tiao; Jin-Bor Chen; Chia-Wei Liou
Journal:  Oxid Med Cell Longev       Date:  2012-12-06       Impact factor: 6.543

9.  Oxidative phosphorylation and lacunar stroke: Genome-wide enrichment analysis of common variants.

Authors:  Matthew Traylor; Christopher D Anderson; Robert Hurford; Steve Bevan; Hugh S Markus
Journal:  Neurology       Date:  2015-12-16       Impact factor: 9.910

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.